Literature DB >> 30912232

Can Aliskiren "COMPLEMENT" our management of kidney disease?

Sheena Pramod1, Bisher O Mustafa1, Zeid J Khitan1.   

Abstract

Entities:  

Keywords:  Aliskiren; complement; glomerular; renin

Mesh：

Substances：

Year:  2019        PMID： 30912232      PMCID： PMC8030379          DOI： 10.1111/jch.13524

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  Aliskiren inhibits renin-mediated complement activation.

Authors:  Zivile D Békássy; Ann-Charlotte Kristoffersson; Johan Rebetz; Ramesh Tati; Anders I Olin; Diana Karpman
Journal:  Kidney Int       Date:  2018-06-05       Impact factor: 10.612

Review 2.  New approaches to blockade of the renin-angiotensin-aldosterone system: characteristics and usefulness of the direct renin inhibitor aliskiren.

Authors:  Atsuhiro Ichihara; Mariyo Sakoda; Asako Kurauchi-Mito; Tatsuya Narita; Kenichiro Kinouchi; Kanako Bokuda; Hiroshi Itoh
Journal:  J Pharmacol Sci       Date:  2010-07-27       Impact factor: 3.337

3.  Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.

Authors:  Jeanette M Wood; Christian R Schnell; Frederic Cumin; Joël Menard; Randy L Webb
Journal:  J Hypertens       Date:  2005-02       Impact factor: 4.844

Review 4.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

5.  Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.

Authors:  F Persson; P Rossing; K J Schjoedt; T Juhl; L Tarnow; C D A Stehouwer; C Schalkwijk; F Boomsma; E Frandsen; H-H Parving
Journal:  Kidney Int       Date:  2008-03-12       Impact factor: 10.612

6.  Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.

Authors:  Felix Waldmeier; Ulrike Glaenzel; Bernard Wirz; Lukas Oberer; Dietmar Schmid; Michael Seiberling; Jessica Valencia; Gilles-Jacques Riviere; Peter End; Sujata Vaidyanathan
Journal:  Drug Metab Dispos       Date:  2007-05-17       Impact factor: 3.922

7.  Can Aliskiren "COMPLEMENT" our management of kidney disease?

Authors:  Sheena Pramod; Bisher O Mustafa; Zeid J Khitan
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-26       Impact factor: 3.738

8.  Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats.

Authors:  D J Kelly; Y Zhang; G Moe; G Naik; R E Gilbert
Journal:  Diabetologia       Date:  2007-09-08       Impact factor: 10.122
  8 in total
  1 in total

1.  Can Aliskiren "COMPLEMENT" our management of kidney disease?

Authors:  Sheena Pramod; Bisher O Mustafa; Zeid J Khitan
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-26       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.